Lingli Chen

6.0k total citations · 3 hit papers
103 papers, 4.0k citations indexed

About

Lingli Chen is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Lingli Chen has authored 103 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 28 papers in Molecular Biology and 24 papers in Surgery. Recurrent topics in Lingli Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Nanoparticle-Based Drug Delivery (10 papers). Lingli Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Nanoparticle-Based Drug Delivery (10 papers). Lingli Chen collaborates with scholars based in China, United States and Australia. Lingli Chen's co-authors include Yaping Li, Haijun Yu, Qi Yin, Wangwen Gu, Zhiwen Zhang, Qingshuo Meng, Jinghan Su, Huiping Sun, Pengcheng Zhang and Yuan Ji and has published in prestigious journals such as Advanced Materials, PLoS ONE and Nature Cell Biology.

In The Last Decade

Lingli Chen

97 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors

2016 540 citations Qingshuo Meng, Qi Yin et al. profile →
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

2021 159 citations Yuan Ji, Lingli Chen et al. profile →
The Interaction between Flavonoids and Intestinal Microbes: A Review

2023 105 citations Lingli Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingli Chen China	32	1.5k	1.1k	772	765	621	103	4.0k
Song Li United States	43	2.7k 1.8×	1.1k 1.0×	873 1.1×	1.2k 1.6×	313 0.5×	171	5.8k
Yao Fu China	36	1.9k 1.2×	866 0.8×	378 0.5×	1.1k 1.5×	391 0.6×	161	4.2k
Xia Liu China	32	1.9k 1.3×	452 0.4×	645 0.8×	466 0.6×	257 0.4×	157	4.7k
Caiyan Zhao China	31	757 0.5×	974 0.8×	285 0.4×	441 0.6×	357 0.6×	107	3.1k
Xizhong Shen China	47	3.9k 2.5×	923 0.8×	799 1.0×	405 0.5×	414 0.7×	181	6.7k
Meixiao Zhan China	33	1.2k 0.8×	852 0.7×	396 0.5×	380 0.5×	374 0.6×	115	3.1k
Rui Xie China	39	2.3k 1.5×	1.0k 0.9×	704 0.9×	342 0.4×	526 0.8×	146	4.9k
Maria Manuela Gaspar Portugal	35	1.3k 0.8×	742 0.6×	421 0.5×	774 1.0×	354 0.6×	131	3.6k
Guangying Cui China	33	2.1k 1.4×	381 0.3×	588 0.8×	207 0.3×	308 0.5×	82	3.4k

Countries citing papers authored by Lingli Chen

Since Specialization

Citations

This map shows the geographic impact of Lingli Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingli Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingli Chen more than expected).

Fields of papers citing papers by Lingli Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingli Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingli Chen. The network helps show where Lingli Chen may publish in the future.

Co-authorship network of co-authors of Lingli Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lingli Chen. A scholar is included among the top collaborators of Lingli Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingli Chen. Lingli Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Lingli, et al.. (2025). Lead exposure disrupts cytoskeletal arrangement and perturbs glucose metabolism in nerve cells through activation of the RhoA/ROCK signaling pathway. Journal of Trace Elements in Medicine and Biology. 89. 127663–127663.

Luo, Rongkui, Lingli Chen, Huimei Wang, et al.. (2025). CPZ. The American Journal of Surgical Pathology. 49(7). 711–729. 1 indexed citations

Chen, Lingli, et al.. (2025). Cross‐Referencing Multifluid Metabolic Profiles on Hollow Dodecahedral Nanocages for Enhanced Disease Status Identification. Small. 21(9). e2410638–e2410638. 1 indexed citations

Hang, Xiang, Rongkui Luo, Yunzhi Wang, et al.. (2024). Proteogenomic insights into the biology and treatment of pan-melanoma. Cell Discovery. 10(1). 78–78. 3 indexed citations

Zhang, Xinyi, et al.. (2024). Clinical and pathological observation of conversion therapy for malignant peritoneal mesothelioma: a case report and literature review. Pathology & Oncology Research. 29. 1611577–1611577. 3 indexed citations

Guo, Dajing, Xiaojing He, Xi Liu, et al.. (2023). The MR Imaging of Primary Intrahepatic Lymphoepithelioma-like Cholangiocarcinoma: A Diagnostic Challenge. Diagnostics. 13(18). 2998–2998.

Zhu, Jianyu & Lingli Chen. (2023). LincRNA-p21 Promotes Cellular Senescence by Down-regulating theWnt/β-catenin Pathway in MPP+-treated SH-SY5Y Cells. Combinatorial Chemistry & High Throughput Screening. 26(14). 2476–2486. 2 indexed citations

Chen, Lingli, et al.. (2023). Mechanisms and active substances of targeting lipid peroxidation in ferroptosis regulation. Food Science and Human Wellness. 13(5). 2502–2518. 1 indexed citations

Liu, Liheng, Mingliang Wang, Fei Jiang, et al.. (2023). Distinct radiological features of lymphoepithelioma-like intrahepatic cholangiocarcinoma: comparison with classical intrahepatic cholangiocarcinoma. Abdominal Radiology. 48(6). 2038–2048. 4 indexed citations

10.

Zhang, Wanli, Lingli Chen, & Min Lou. (2022). Association of Elevated Serum Uric Acid with Nerve Conduction Function and Peripheral Neuropathy Stratified by Gender and Age in Type 2 Diabetes Patients. Brain Sciences. 12(12). 1704–1704. 4 indexed citations

11.

Xu, Chen, Miaomiao Sun, Hongfang Jin, et al.. (2022). Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China. Diagnostic Pathology. 17(1). 54–54. 4 indexed citations

12.

Liu, Yalan, Lingli Chen, Dongxian Jiang, et al.. (2021). HER2 promotes epithelial-mesenchymal transition through regulating osteopontin in gastric cancer. Pathology - Research and Practice. 227. 153643–153643. 8 indexed citations

13.

Li, Wei, Qian Li, Yiyi Yu, et al.. (2020). <p>Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma</p>. Cancer Management and Research. Volume 12. 11113–11119. 21 indexed citations

14.

Qi, Yangyang, Yuan Chang, Zewei Wang, et al.. (2019). Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response. Cancer Immunology Immunotherapy. 68(12). 2067–2080. 36 indexed citations

15.

Li, Ruokun, Mengsu Zeng, Jinwei Qiang, et al.. (2015). Value of MR susceptibility weighted imaging for characterization of small hepatocellular carcinoma in cirrhotic livers. Zhonghua fangshexian yixue zazhi. 49(7). 520–524. 1 indexed citations

16.

Sheng, Ruofan, Mengsu Zeng, Shengxiang Rao, Yuan Ji, & Lingli Chen. (2014). MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study. Clinical Imaging. 38(3). 265–272. 33 indexed citations

17.

Xiao, Jisheng, Xiaopin Duan, Qingshuo Meng, et al.. (2014). Effective delivery of p65 shRNA by optimized Tween 85-polyethyleneimine conjugate for inhibition of tumor growth and lymphatic metastasis. Acta Biomaterialia. 10(6). 2674–2683. 15 indexed citations

18.

Li, Ruokun, et al.. (2013). Susceptibility weighted imaging of multistep hepatocarcinogenesis in cirrhotic livers: correlation with pathology. Zhonghua fangshexian yixue zazhi. 47(11). 1014–1018.

19.

Yu, Haijun, Yonglong Zou, Lei Jiang, et al.. (2013). Induction of apoptosis in non-small cell lung cancer by downregulation of MDM2 using pH-responsive PMPC-b-PDPA/siRNA complex nanoparticles. Biomaterials. 34(11). 2738–2747. 58 indexed citations

20.

Han, Lei, Lei Jiang, Hui Tan, et al.. (2013). An Atypical Case of IgG4-Related Sclerosing Pancreatitis on PET/CT Imaging. Clinical Nuclear Medicine. 39(3). e236–e238. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact